Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Suven Life Sciences Ltd.

http://www.suven.com/

Latest From Suven Life Sciences Ltd.

Aceto Moves Ahead With Rising Divestment

Aceto has received approval to divest its Rising Pharmaceuticals unit to Shore Suven Pharma for $15m as part of bankruptcy proceedings.

Deals Strategy

Can Axovant's RVT-1 Redeem 5HT6 Class After Lundbeck's Idalopirdine Failure?

Lundbeck says it remains committed to developing new Alzheimer's disease drugs with a variety of different mechanisms, after the unsurprising failure of 5HT6 antagonist idalopirdine in two more Phase III studies.

Neurology Clinical Trials

Full Monty On Pfizer’s Failed 5-HT6 Alzheimer’s Drug Leaves Hope For Class

Presentation of data at Alzheimer’s Association International Conference highlights failure of Pfizer’s 5HT6 antagonist PF-05212377, while still leaving room to hope for others in class like Lundbeck’s idalopirdine and Axovant’s RVT-101

Research & Development Clinical Trials

Who Will Get First AD Drug To Market In Over A Decade?

Alzheimer's disease (AD) drug developer Axovant Sciences, which earlier this year raised a record-breaking sum of cash, has launched a large Phase III study for its 5-HT6 receptor antagonist, RVT-101– a move it hopes will set the company up to seek the first approval for any new AD product in over a decade.

Neurology Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Drug Discovery Tools
    • Drug Discovery Tools
      • Molecular Diversity
  • Other Names / Subsidiaries
    • SUVEN LIFE Sciences Limited
    • Suven Neurosciences Inc
    • Suven Inc
    • SUVEN PHARMACEUTICALS LIMITED
UsernamePublicRestriction

Register